智通财经APP获悉，春立医疗(01858)盘中涨超10%，截至发稿，涨5.46%，报10.82港元，成交额6406.83万港元。
华创证券发布研报称，预计运动医学集采和关节续标对春立医疗的渠道退换货影响在24年基本结束，后续随着集采加速国产替代、人口老龄化推动国内骨科手术量持续较快增长、海外业务快速拓展，2025年公司有望重回高增长。
该行指出，受益于公司长期较高的研发投入，新产品不断获批。25年1-4月期间，公司的正畸支抗钉、电池供电骨组织手术设备、牙科聚合物基复合树脂、钛网板系统、非融合棘突植入物、光固化流动树脂、自稳定型椎间融合器等多个产品获批，公司口腔产品线得到完善，并进一步增长骨科产品体系竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.